Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
53.4M
-
Number of holders
-
59
-
Total 13F shares, excl. options
-
21.4M
-
Shares change
-
+7.44M
-
Total reported value, excl. options
-
$154M
-
Value change
-
+$53.7M
-
Put/Call ratio
-
3.83
-
Number of buys
-
45
-
Number of sells
-
-12
-
Price
-
$7.17
Significant Holders of scPharmaceuticals Inc. - Common Stock (SCPH) as of Q4 2022
67 filings reported holding SCPH - scPharmaceuticals Inc. - Common Stock as of Q4 2022.
scPharmaceuticals Inc. - Common Stock (SCPH) has 59 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21.4M shares
of 53.4M outstanding shares and own 40.12% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (5.56M shares), 5AM Venture Management, LLC (2.73M shares), AIGH Capital Management LLC (2.55M shares), ARMISTICE CAPITAL, LLC (2.15M shares), RA CAPITAL MANAGEMENT, L.P. (1.86M shares), PERCEPTIVE ADVISORS LLC (952K shares), VANGUARD GROUP INC (877K shares), MILLENNIUM MANAGEMENT LLC (826K shares), Worth Venture Partners, LLC (627K shares), and KENNEDY CAPITAL MANAGEMENT LLC (227K shares).
This table shows the top 59 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.